The 5th edition of the World Health Organization (WHO) Classification of Head and Neck
Tumors opened to online access in March 2022. This edition is conceptually similar to the …

Ameloblastomas are benign but locally invasive neoplasms which may grow to massive
proportions and cause significant morbidity. Although some types of ameloblastoma can be …

The 4th edition of the World Health Organization's Classification of Head and Neck Tumours
was published in January of 2017. This article provides a summary of the changes to …

Objective The objective of this systematic review with meta‐analysis was to critically
evaluate the available data on the association of the BRAF V600E mutation and recurrence …

BRAF V600E is the most common mutation in conventional ameloblastoma (AM) of the
mandible. In contrast, maxillary AMs appear to harbor more frequently RAS, FGFR2, or SMO …

BACKGROUND Ameloblastomas are common benign epithelial odontogenic neoplasms
that present an aggressive and unpredictable behavior that may modify treatment strategies …

Numerous signal transduction pathways are closely associated with the occurrence,
development, and prognosis of ameloblastoma (AM). Mitogen‐activated protein kinase …

The advances in molecular technologies have allowed a better understanding of the
molecular basis of odontogenic cysts and tumours. PTCH1 mutations have been reported in …

Objective The objective of this systematic review with meta‐analysis was to critically
evaluate the available data on sensitivity and specificity of IHC compared with molecular …

Simple Summary Ameloblastoma is a benign odontogenic tumour, and the patient always
presents at a later stage when the tumour is already in an aggressive state. The finding of …